A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis
Clinical trial NCT03275025 · COMPLETED
Trial details
- NCT number
- NCT03275025
- Sponsor
- Yungjin Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2019-11-19
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.